Cargando…
Inhibition of eIF2α dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis
BACKGROUND: The ErbB2/Her2/Neu receptor tyrosine kinase is amplified in ~30% of human breast cancers. Phosphorylation of the translation initiation factor, eIF2α inhibits global protein synthesis and activates a stress signaling and growth suppressive program. We have shown that forced phosphorylati...
Autores principales: | Sequeira, Sharon J, Wen, Huei Chi, Avivar-Valderas, Alvaro, Farias, Eduardo F, Aguirre-Ghiso, Julio A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754445/ https://www.ncbi.nlm.nih.gov/pubmed/19754954 http://dx.doi.org/10.1186/1471-2121-10-64 |
Ejemplares similares
-
Inhibition of Proliferation by PERK Regulates Mammary Acinar Morphogenesis and Tumor Formation
por: Sequeira, Sharon J., et al.
Publicado: (2007) -
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
por: Chang, Joan, et al.
Publicado: (2013) -
ErbB3 is required for ductal morphogenesis in the mouse mammary gland
por: Jackson-Fisher, Amy J, et al.
Publicado: (2008) -
Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice
por: Parris, Amanda B., et al.
Publicado: (2017) -
ErbB2 Dephosphorylation and Anti-Proliferative Effects of Neuregulin-1 in ErbB2-Overexpressing Cells; Re-evaluation of Their Low-Affinity Interaction
por: Wang, Ran, et al.
Publicado: (2013)